SCHEMBL7411142

SCHEMBL7411142

O=c1c2cccnc2c(-c2cccc(Cl)c2)cn1Cc1ccncc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.64
PDE4B Q07343 3/20 0.64
PDE4C Q08493 2/20 0.64
PDE4D Q08499 2/20 0.64
PDE3B Q13370 1/20 0.64
PDE3A Q14432 1/20 0.64
DHPS P49366 1/20 0.42
BRD4 O60885 1/20 0.41
KDR P35968 2/20 0.40
GLO1 Q04760 1/20 0.40
BRD9 Q9H8M2 1/20 0.39
BRD7 Q9NPI1 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GRK2 P25098 1/20 0.39
TRPC5 Q9UL62 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTR6 P50406 1/20 0.38
FSCN1 Q16658 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7415715 0.92 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7416298 0.87 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7408107 0.85 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7416549 0.85 PDE4A (0.50) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7419303 0.83 PDE4A (0.48) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL8802833 0.83 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7411229 0.81 PDE4A (0.64) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7415586 0.81 DHPS (0.51) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7410529 0.80 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7364942 0.78 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5466697-A 8-phenyl-1,6-naphthyridin-5-ones SYNTEX (U.S.A.) INC. (US) 1995-11-14 US disclosed